InvestorsHub Logo
Post# of 252251
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: genisi post# 148055

Monday, 12/03/2012 3:20:18 PM

Monday, December 03, 2012 3:20:18 PM

Post# of 252251
MRK's lead BACE inhibitor - MK-8931

I thought they will do a smaller phase II for safety and biomarkers data only.

So according to today's PR

initially evaluate the safety of MK-8931 in a cohort of 200 patients prior to advancing into a larger Phase III study.

How long will this phase II be? and why treat "mild-to-moderate" when we know chances are moderate is too late?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.